Linked Life Data

16355598

Source:http://linkedlifedata.com/resource/pubmed/id/16355598

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-12-16
pubmed:abstractText
There is concern about the increasing transmission of drug-resistant HIV to uninfected persons. Harboring a resistant variant of HIV-1 can influence the antiviral effect of the initial treatment regimen. These strains may be resistant to 1 or more of the existing classes of antiretrovirals. Use of resistance testing before initiating antiretroviral therapy to identify persons with acquired resistance is becoming more common. For these persons, as well as for highly treatment-experienced patients who may be transmitting drug-resistant HIV, the use of ritonavir-boosted protease inhibitors, possibly including investigational agents that retain activity against these isolates, may be a valuable approach to treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1053-0894
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
683-6, 689-90
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Impact of HIV protease inhibitor resistance in treatment-naive populations in the united states.
pubmed:affiliation
Duke University Medical Center, Durham, NC, USA.
pubmed:publicationType
Journal Article